These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34387523)

  • 21. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
    Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
    J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-Term Effects of Botulinum Toxin-A Injection on the Medial Gastrocnemius Histological Features in Ambulant Children with Cerebral Palsy: A Longitudinal Pilot Study.
    Deschrevel J; Andries A; Maes K; De Beukelaer N; Corvelyn M; Staut L; De Houwer H; Costamagna D; Desloovere K; Van Campenhout A; Gayan-Ramirez G
    Toxins (Basel); 2024 Jan; 16(2):. PubMed ID: 38393147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
    Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
    Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum Toxin in the Management of Children with Cerebral Palsy.
    Multani I; Manji J; Hastings-Ison T; Khot A; Graham K
    Paediatr Drugs; 2019 Aug; 21(4):261-281. PubMed ID: 31257556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Botulinum Toxin A Injection on Ambulation Capacity in Patients with Cerebral Palsy.
    Çağlar Okur S; Uğur M; Şenel K
    Dev Neurorehabil; 2019 May; 22(4):288-291. PubMed ID: 30095354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parameters for predicting favorable responses to botulinum toxin in children with cerebral palsy.
    Fattal-Valevski A; Giladi N; Domanievitz D; Zuk L; Masterman R; Harel S; Wientroub S; Hayek S
    J Child Neurol; 2002 Apr; 17(4):272-7. PubMed ID: 12088083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy?
    Bar-On L; Van Campenhout A; Desloovere K; Aertbeliën E; Huenaerts C; Vandendoorent B; Nieuwenhuys A; Molenaers G
    Arch Phys Med Rehabil; 2014 Mar; 95(3):515-23. PubMed ID: 23994052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of botulinum toxin serotype A on sleep problems in children with cerebral palsy and on mothers sleep quality and depression.
    Binay Safer V; Ozbudak Demir S; Ozkan E; Demircioglu Guneri F
    Neurosciences (Riyadh); 2016 Oct; 21(4):331-337. PubMed ID: 27744462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
    Alhusaini AA; Crosbie J; Shepherd RB; Dean CM; Scheinberg A
    Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Motor endplate-targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy.
    Van Campenhout A; Bar-On L; Desloovere K; Huenaerts C; Molenaers G
    Dev Med Child Neurol; 2015 May; 57(5):476-83. PubMed ID: 25557985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is botulinum toxin type A more effective and safer than other treatments for the management of lower limb spasticity in children with cerebral palsy? A Cochrane Review summary with commentary.
    Kim H; Kolaski K
    NeuroRehabilitation; 2021; 49(1):161-164. PubMed ID: 34366300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of botulinum toxin A in management of children with cerebral palsy.
    Friedman BC; Goldman RD
    Can Fam Physician; 2011 Sep; 57(9):1006-73. PubMed ID: 21918142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT; Doherty GM; Fairhurst CB
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of botulinum toxin type A efficacy on spasticity and functional outcome in children with spastic cerebral palsy.
    Colovic H; Dimitrijevic L; Stankovic I; Nikolic D; Radovic-Janosevic D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar; 156(1):41-7. PubMed ID: 22580859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of botulinum toxin guided by electric stimulation on spasticity in ankle plantar flexor of children with cerebral palsy: a randomized trial].
    Xu KS; Yan TB; Mai JN
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):913-7. PubMed ID: 17254459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Botulinum toxin type A for the treatment of spasticity in children with cerebral palsy].
    Dimitrijević L; Stanković I; Zivković V; Mikov A; Colović H; Janković I
    Vojnosanit Pregl; 2007 Aug; 64(8):513-8. PubMed ID: 17874717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
    Choi JY; Jung S; Rha DW; Park ES
    Yonsei Med J; 2016 Mar; 57(2):496-504. PubMed ID: 26847306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of botulinum toxin A and/or bimanual task-oriented therapy on upper extremity impairments in unilateral Cerebral Palsy: an explorative study.
    Speth L; Janssen-Potten Y; Leffers P; Rameckers E; Defesche A; Winkens B; Becher J; Smeets R; Vles JS
    Eur J Paediatr Neurol; 2015 May; 19(3):337-48. PubMed ID: 25661064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of spasticity in cerebral palsy with botulinum toxin].
    Calderón-González R; Calderón-Sepúlveda RF
    Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.